Übersetzung und Analyse von Wörtern durch künstliche Intelligenz ChatGPT
Auf dieser Seite erhalten Sie eine detaillierte Analyse eines Wortes oder einer Phrase mithilfe der besten heute verfügbaren Technologie der künstlichen Intelligenz:
- wie das Wort verwendet wird
- Häufigkeit der Nutzung
- es wird häufiger in mündlicher oder schriftlicher Rede verwendet
- Wortübersetzungsoptionen
- Anwendungsbeispiele (mehrere Phrasen mit Übersetzung)
- Etymologie
NSAID$505047$ - Übersetzung nach Englisch
![One of the first advertisements for Bayer Aspirin, published in ''[[The New York Times]]'' in 1917](https://commons.wikimedia.org/wiki/Special:FilePath/Bayer Aspirin ad, NYT, February 19, 1917.jpg?width=200 "One of the first advertisements for Bayer Aspirin, published in ''[[The New York Times]]'' in 1917")
![Burana 600 mg – [[ibuprofen]] package](https://commons.wikimedia.org/wiki/Special:FilePath/Burana600.jpg?width=200 "Burana 600 mg – [[ibuprofen]] package")
![over-the-counter]] non-steroidal anti-inflammatory drug](https://commons.wikimedia.org/wiki/Special:FilePath/NSAID label.jpg?width=200 "over-the-counter]] non-steroidal anti-inflammatory drug")
Wikipedia
Analgesic nephropathy is injury to the kidneys caused by analgesic medications such as aspirin, bucetin, phenacetin, and paracetamol. The term usually refers to damage induced by excessive use of combinations of these medications, especially combinations that include phenacetin. It may also be used to describe kidney injury from any single analgesic medication.
The specific kidney injuries induced by analgesics are renal papillary necrosis and chronic interstitial nephritis. They appear to result from decreased blood flow to the kidney, rapid consumption of antioxidants, and subsequent oxidative damage to the kidney. This kidney damage may lead to progressive chronic kidney failure, abnormal urinalysis results, high blood pressure, and anemia. A small proportion of individuals with analgesic nephropathy may develop end-stage kidney disease.
Analgesic nephropathy was once a common cause of kidney injury and end-stage kidney disease in parts of Europe, Australia, and the United States. In most areas, its incidence has declined sharply since the use of phenacetin fell in the 1970s and 1980s.
